Your browser doesn't support javascript.
loading
High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.
De Nardo, Dominic; Labzin, Larisa I; Kono, Hajime; Seki, Reiko; Schmidt, Susanne V; Beyer, Marc; Xu, Dakang; Zimmer, Sebastian; Lahrmann, Catharina; Schildberg, Frank A; Vogelhuber, Johanna; Kraut, Michael; Ulas, Thomas; Kerksiek, Anja; Krebs, Wolfgang; Bode, Niklas; Grebe, Alena; Fitzgerald, Michael L; Hernandez, Nicholas J; Williams, Bryan R G; Knolle, Percy; Kneilling, Manfred; Röcken, Martin; Lütjohann, Dieter; Wright, Samuel D; Schultze, Joachim L; Latz, Eicke.
Affiliation
  • De Nardo D; 1] Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany. [2].
  • Labzin LI; 1] Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany. [2].
  • Kono H; Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
  • Seki R; Department of Clinical Laboratory Science, Teikyo University Faculty of Medical Technology, Tokyo, Japan.
  • Schmidt SV; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Beyer M; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Xu D; 1] Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia. [2] Institute of Ageing Research, Hangzhou Normal University School of Medicine, Hangzhou, China.
  • Zimmer S; Department of Medicine/Cardiology, University of Bonn, Bonn, Germany.
  • Lahrmann C; Department of Medicine/Cardiology, University of Bonn, Bonn, Germany.
  • Schildberg FA; Institutes of Molecular Medicine and Experimental Immunology, University of Bonn, Bonn, Germany.
  • Vogelhuber J; Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany.
  • Kraut M; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Ulas T; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Kerksiek A; Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
  • Krebs W; Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Bode N; Department of Medicine/Cardiology, University of Bonn, Bonn, Germany.
  • Grebe A; Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany.
  • Fitzgerald ML; Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Hernandez NJ; Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Williams BR; Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia.
  • Knolle P; 1] Institutes of Molecular Medicine and Experimental Immunology, University of Bonn, Bonn, Germany. [2] Institute of Molecular Immunology, Technical University of Munich, Munich, Germany.
  • Kneilling M; 1] Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. [2] Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tuebingen, Germany.
  • Röcken M; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Lütjohann D; Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
  • Wright SD; Cardiovascular Therapeutics, CSL Limited, Parkville, Australia.
  • Schultze JL; 1] Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. [2].
  • Latz E; 1] Institute of Innate Immunity, University Hospitals, Biomedical Centre, University of Bonn, Bonn, Germany. [2] Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. [3] German Center for Neurodegenerative Diseases, Bonn, Germany.
Nat Immunol ; 15(2): 152-60, 2014 Feb.
Article in En | MEDLINE | ID: mdl-24317040

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Cholesterol / Atherosclerosis / Activating Transcription Factor 3 / Inflammation / Lipoproteins, HDL / Macrophages Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2014 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Cholesterol / Atherosclerosis / Activating Transcription Factor 3 / Inflammation / Lipoproteins, HDL / Macrophages Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2014 Type: Article